Last reviewed · How we verify
JS207 in combination with 9MW2821 — Competitive Intelligence Brief
phase 2
Small molecule
Live · refreshed every 30 min
Target snapshot
JS207 in combination with 9MW2821 (JS207 in combination with 9MW2821) — Shanghai Junshi Bioscience Co., Ltd..
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| JS207 in combination with 9MW2821 TARGET | JS207 in combination with 9MW2821 | Shanghai Junshi Bioscience Co., Ltd. | phase 2 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- JS207 in combination with 9MW2821 CI watch — RSS
- JS207 in combination with 9MW2821 CI watch — Atom
- JS207 in combination with 9MW2821 CI watch — JSON
- JS207 in combination with 9MW2821 alone — RSS
Cite this brief
Drug Landscape (2026). JS207 in combination with 9MW2821 — Competitive Intelligence Brief. https://druglandscape.com/ci/js207-in-combination-with-9mw2821. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab